Annual EBITDA
-$45.24 M
-$21.80 M-92.99%
31 December 2023
Summary:
BioLife Solutions annual earnings before interest, taxes, depreciation & amortization is currently -$45.24 million, with the most recent change of -$21.80 million (-92.99%) on 31 December 2023. During the last 3 years, it has fallen by -$46.31 million (-4327.85%). BLFS annual EBITDA is now -1862.29% below its all-time high of $2.57 million, reached on 31 December 2019.BLFS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$853.00 K
+$5.28 M+119.29%
30 September 2024
Summary:
BioLife Solutions quarterly earnings before interest, taxes, depreciation & amortization is currently $853.00 thousand, with the most recent change of +$5.28 million (+119.29%) on 30 September 2024. Over the past year, it has increased by +$12.82 million (+107.13%). BLFS quarterly EBITDA is now -98.54% below its all-time high of $58.57 million, reached on 31 December 2022.BLFS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$37.71 M
+$12.82 M+25.37%
30 September 2024
Summary:
BioLife Solutions TTM earnings before interest, taxes, depreciation & amortization is currently -$37.71 million, with the most recent change of +$12.82 million (+25.37%) on 30 September 2024. Over the past year, it has dropped by -$72.61 million (-208.04%). BLFS TTM EBITDA is now -193.63% below its all-time high of $40.27 million, reached on 30 June 2023.BLFS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.0% | +107.1% | -208.0% |
| 3 y3 years | -4327.9% | +111.7% | -362.7% |
| 5 y5 years | -83.4% | -92.1% | -21.3% |
BLFS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4327.9% | at low | -98.5% | +101.2% | -193.6% | +60.3% |
| 5 y | 5 years | -1862.3% | at low | -98.5% | +101.2% | -193.6% | +60.3% |
| alltime | all time | -1862.3% | at low | -98.5% | +101.2% | -193.6% | +60.3% |
BioLife Solutions EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $853.00 K(-119.3%) | -$37.71 M(-25.4%) |
| June 2024 | - | -$4.42 M(-41.8%) | -$50.52 M(+5.8%) |
| Mar 2024 | - | -$7.61 M(-71.3%) | -$47.77 M(-4.8%) |
| Dec 2023 | -$45.24 M(+93.0%) | -$26.53 M(+121.8%) | -$50.20 M(-243.8%) |
| Sept 2023 | - | -$11.96 M(+614.6%) | $34.90 M(-13.3%) |
| June 2023 | - | -$1.67 M(-83.3%) | $40.27 M(-233.5%) |
| Mar 2023 | - | -$10.03 M(-117.1%) | -$30.17 M(+28.6%) |
| Dec 2022 | -$23.44 M(+31.8%) | $58.57 M(-988.6%) | -$23.46 M(-75.1%) |
| Sept 2022 | - | -$6.59 M(-90.9%) | -$94.20 M(-0.7%) |
| June 2022 | - | -$72.12 M(+2072.3%) | -$94.89 M(+290.0%) |
| Mar 2022 | - | -$3.32 M(-72.7%) | -$24.33 M(+23.0%) |
| Dec 2021 | -$17.78 M(-1762.1%) | -$12.17 M(+66.9%) | -$19.77 M(+142.7%) |
| Sept 2021 | - | -$7.29 M(+368.7%) | -$8.15 M(+998.2%) |
| June 2021 | - | -$1.55 M(-225.8%) | -$742.00 K(-210.3%) |
| Mar 2021 | - | $1.24 M(-328.5%) | $673.00 K(-37.1%) |
| Dec 2020 | $1.07 M(-58.3%) | -$541.00 K(-558.5%) | $1.07 M(-86.6%) |
| Sept 2020 | - | $118.00 K(-184.3%) | $7.97 M(-57.2%) |
| June 2020 | - | -$140.00 K(-108.6%) | $18.65 M(-19.8%) |
| Mar 2020 | - | $1.63 M(-74.3%) | $23.26 M(+806.1%) |
| Dec 2019 | $2.57 M(-110.4%) | $6.36 M(-41.0%) | $2.57 M(-108.3%) |
| Sept 2019 | - | $10.79 M(+141.6%) | -$31.08 M(-23.4%) |
| June 2019 | - | $4.47 M(-123.4%) | -$40.56 M(-7.4%) |
| Mar 2019 | - | -$19.06 M(-30.1%) | -$43.80 M(+77.6%) |
| Dec 2018 | -$24.66 M(+1141.8%) | -$27.28 M(-2173.3%) | -$24.66 M(-1250.7%) |
| Sept 2018 | - | $1.32 M(+7.6%) | $2.14 M(+261.3%) |
| June 2018 | - | $1.22 M(+1391.5%) | $593.30 K(-149.2%) |
| Mar 2018 | - | $82.00 K(-117.2%) | -$1.21 M(-39.2%) |
| Dec 2017 | -$1.99 M(-73.8%) | -$477.70 K(+104.1%) | -$1.99 M(-59.7%) |
| Sept 2017 | - | -$234.00 K(-59.4%) | -$4.92 M(-15.5%) |
| June 2017 | - | -$576.90 K(-17.3%) | -$5.83 M(-15.2%) |
| Mar 2017 | - | -$697.40 K(-79.6%) | -$6.87 M(-9.3%) |
| Dec 2016 | -$7.57 M(+62.0%) | -$3.42 M(+199.5%) | -$7.58 M(+38.3%) |
| Sept 2016 | - | -$1.14 M(-29.6%) | -$5.48 M(-1.3%) |
| June 2016 | - | -$1.62 M(+15.6%) | -$5.55 M(+11.1%) |
| Mar 2016 | - | -$1.40 M(+6.4%) | -$4.99 M(+6.9%) |
| Dec 2015 | -$4.67 M(+63.1%) | -$1.32 M(+8.8%) | -$4.67 M(+9.2%) |
| Sept 2015 | - | -$1.21 M(+13.5%) | -$4.28 M(+10.6%) |
| June 2015 | - | -$1.07 M(-1.1%) | -$3.86 M(+6.7%) |
| Mar 2015 | - | -$1.08 M(+16.6%) | -$3.62 M(+26.4%) |
| Dec 2014 | -$2.87 M(+2919.4%) | -$923.60 K(+15.6%) | -$2.87 M(+31.6%) |
| Sept 2014 | - | -$799.10 K(-2.9%) | -$2.18 M(+51.5%) |
| June 2014 | - | -$823.10 K(+157.5%) | -$1.44 M(+120.6%) |
| Mar 2014 | - | -$319.60 K(+35.9%) | -$651.60 K(+586.6%) |
| Dec 2013 | -$94.90 K(-87.5%) | -$235.20 K(+296.0%) | -$94.90 K(-24.7%) |
| Sept 2013 | - | -$59.40 K(+58.8%) | -$126.10 K(-31.0%) |
| June 2013 | - | -$37.40 K(-115.8%) | -$182.70 K(-57.3%) |
| Mar 2013 | - | $237.10 K(-189.0%) | -$427.70 K(-43.5%) |
| Dec 2012 | -$756.50 K(-36.3%) | -$266.40 K(+129.7%) | -$756.40 K(+7.9%) |
| Sept 2012 | - | -$116.00 K(-58.9%) | -$701.30 K(-19.2%) |
| June 2012 | - | -$282.40 K(+208.3%) | -$867.70 K(+4.1%) |
| Mar 2012 | - | -$91.60 K(-56.6%) | -$833.40 K(-29.9%) |
| Dec 2011 | -$1.19 M(-10.2%) | -$211.30 K(-25.2%) | -$1.19 M(-6.4%) |
| Sept 2011 | - | -$282.40 K(+13.8%) | -$1.27 M(+1.4%) |
| June 2011 | - | -$248.10 K(-44.5%) | -$1.25 M(-8.8%) |
| Mar 2011 | - | -$446.70 K(+52.4%) | -$1.37 M(+4.3%) |
| Dec 2010 | -$1.32 M(-39.6%) | -$293.20 K(+10.9%) | -$1.32 M(+7.3%) |
| Sept 2010 | - | -$264.30 K(-28.3%) | -$1.23 M(-10.4%) |
| June 2010 | - | -$368.40 K(-5.7%) | -$1.37 M(-26.6%) |
| Mar 2010 | - | -$390.70 K(+92.0%) | -$1.86 M(-15.2%) |
| Dec 2009 | -$2.19 M(-10.9%) | -$203.50 K(-49.9%) | -$2.20 M(-19.6%) |
| Sept 2009 | - | -$406.20 K(-53.0%) | -$2.73 M(-6.0%) |
| June 2009 | - | -$864.10 K(+19.4%) | -$2.91 M(+10.5%) |
| Mar 2009 | - | -$723.80 K(-1.9%) | -$2.63 M(+6.9%) |
| Dec 2008 | -$2.46 M(-7.2%) | -$738.00 K(+26.9%) | -$2.46 M(+3.9%) |
| Sept 2008 | - | -$581.40 K(-1.1%) | -$2.37 M(-5.2%) |
| June 2008 | - | -$588.00 K(+6.2%) | -$2.50 M(-5.0%) |
| Mar 2008 | - | -$553.70 K(-14.3%) | -$2.63 M(-0.9%) |
| Dec 2007 | -$2.65 M(+83.6%) | -$645.80 K(-9.1%) | -$2.65 M(+8.7%) |
| Sept 2007 | - | -$710.20 K(-1.3%) | -$2.44 M(+15.5%) |
| June 2007 | - | -$719.40 K(+24.8%) | -$2.11 M(+15.8%) |
| Mar 2007 | - | -$576.60 K(+33.0%) | -$1.82 M(+26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | -$1.44 M(+157.3%) | -$433.40 K(+13.3%) | -$1.44 M(+23.7%) |
| Sept 2006 | - | -$382.50 K(-11.5%) | -$1.17 M(+26.1%) |
| June 2006 | - | -$432.00 K(+119.6%) | -$925.80 K(+52.1%) |
| Mar 2006 | - | -$196.70 K(+25.9%) | -$608.50 K(+8.4%) |
| Dec 2005 | -$561.40 K(+14.1%) | -$156.20 K(+10.9%) | -$561.40 K(+44.8%) |
| Sept 2005 | - | -$140.90 K(+22.8%) | -$387.60 K(+1.0%) |
| June 2005 | - | -$114.70 K(-23.3%) | -$383.80 K(-21.8%) |
| Mar 2005 | - | -$149.60 K(-950.0%) | -$490.80 K(-0.3%) |
| Dec 2004 | -$492.20 K(-56.8%) | $17.60 K(-112.8%) | -$492.30 K(+20.5%) |
| Sept 2004 | - | -$137.10 K(-38.2%) | -$408.50 K(-46.2%) |
| June 2004 | - | -$221.70 K(+46.7%) | -$759.90 K(-25.5%) |
| Mar 2004 | - | -$151.10 K(-249.0%) | -$1.02 M(+25.2%) |
| Dec 2003 | -$1.14 M(+152.6%) | $101.40 K(-120.8%) | -$813.90 K(-26.9%) |
| Sept 2003 | - | -$488.50 K(+1.5%) | -$1.11 M(+52.2%) |
| June 2003 | - | -$481.20 K(-984.6%) | -$732.10 K(+25.9%) |
| Mar 2003 | - | $54.40 K(-127.4%) | -$581.30 K(-2.6%) |
| Dec 2002 | -$451.20 K(+69.2%) | -$198.70 K(+86.4%) | -$596.60 K(+19.7%) |
| Sept 2002 | - | -$106.60 K(-67.7%) | -$498.50 K(+29.6%) |
| June 2002 | - | -$330.40 K(-945.0%) | -$384.70 K(+402.9%) |
| Mar 2002 | - | $39.10 K(-138.9%) | -$76.50 K(-93.3%) |
| Dec 2001 | -$266.70 K(-89.8%) | -$100.60 K(-1497.2%) | -$1.14 M(-44.8%) |
| Sept 2001 | - | $7200.00(-132.4%) | -$2.07 M(-24.4%) |
| June 2001 | - | -$22.20 K(-97.8%) | -$2.73 M(-22.9%) |
| Mar 2001 | - | -$1.02 M(-0.1%) | -$3.55 M(+36.2%) |
| Dec 2000 | -$2.60 M(+202.3%) | -$1.03 M(+55.3%) | -$2.60 M(+65.0%) |
| Sept 2000 | - | -$660.70 K(-20.8%) | -$1.58 M(+72.0%) |
| June 2000 | - | -$834.70 K(+909.3%) | -$917.40 K(+1009.3%) |
| Mar 2000 | - | -$82.70 K(-141.6%) | -$82.70 K(-79.4%) |
| Dec 1999 | -$861.20 K(-4.4%) | - | - |
| Dec 1998 | -$901.20 K(-27.1%) | $198.80 K(-298.8%) | -$401.20 K(-8.0%) |
| Sept 1998 | - | -$100.00 K(<-9900.0%) | -$436.00 K(-18.7%) |
| June 1998 | - | $0.00(-100.0%) | -$536.00 K(-52.8%) |
| Mar 1998 | - | -$500.00 K(-404.9%) | -$1.14 M(+78.6%) |
| Dec 1997 | -$1.24 M(+96.8%) | $164.00 K(-182.0%) | -$636.00 K(-20.5%) |
| Sept 1997 | - | -$200.00 K(-66.7%) | -$800.00 K(0.0%) |
| June 1997 | - | -$600.00 K(<-9900.0%) | -$800.00 K(-43.5%) |
| Mar 1997 | - | $0.00(-100.0%) | -$1.42 M(-33.1%) |
| Dec 1996 | -$627.90 K(-79.2%) | - | - |
| Sept 1996 | - | -$200.00 K(-83.6%) | -$2.12 M(-4.5%) |
| June 1996 | - | -$1.22 M(+508.1%) | -$2.22 M(+223.2%) |
| June 1996 | -$3.02 M(+117.7%) | - | - |
| Mar 1996 | - | -$200.00 K(-60.0%) | -$685.70 K(-30.4%) |
| Dec 1995 | - | -$500.00 K(+66.7%) | -$985.70 K(-124.0%) |
| Sept 1995 | - | -$300.00 K(-195.5%) | $4.11 M(+2.5%) |
| June 1995 | -$1.39 M(-42.3%) | $314.30 K(-162.9%) | $4.01 M(+18.1%) |
| Mar 1995 | - | -$500.00 K(-110.9%) | $3.40 M(+17.2%) |
| Dec 1994 | - | $4.60 M(-1250.0%) | $2.90 M(-238.1%) |
| Sept 1994 | - | -$400.00 K(+33.3%) | -$2.10 M(-4.5%) |
| June 1994 | -$2.40 M(-64.2%) | -$300.00 K(-70.0%) | -$2.20 M(-35.3%) |
| Mar 1994 | - | -$1.00 M(+150.0%) | -$3.40 M(-10.5%) |
| Dec 1993 | - | -$400.00 K(-20.0%) | -$3.80 M(-28.3%) |
| Sept 1993 | - | -$500.00 K(-66.7%) | -$5.30 M(-19.7%) |
| June 1993 | -$6.70 M(+42.6%) | -$1.50 M(+7.1%) | -$6.60 M(-35.3%) |
| Mar 1993 | - | -$1.40 M(-26.3%) | -$10.20 M(+17.2%) |
| Dec 1992 | - | -$1.90 M(+5.6%) | -$8.70 M(+10.1%) |
| Sept 1992 | - | -$1.80 M(-64.7%) | -$7.90 M(+31.7%) |
| June 1992 | -$4.70 M(+88.0%) | -$5.10 M(-5200.0%) | -$6.00 M(+62.2%) |
| Mar 1992 | - | $100.00 K(-109.1%) | -$3.70 M(0.0%) |
| Dec 1991 | - | -$1.10 M(-1200.0%) | -$3.70 M(+48.0%) |
| Sept 1991 | - | $100.00 K(-103.6%) | -$2.50 M(-26.5%) |
| June 1991 | -$2.50 M(+66.7%) | -$2.80 M(-2900.0%) | -$3.40 M(+41.7%) |
| Mar 1991 | - | $100.00 K(0.0%) | -$2.40 M(0.0%) |
| Dec 1990 | - | $100.00 K(-112.5%) | -$2.40 M(0.0%) |
| Sept 1990 | - | -$800.00 K(-55.6%) | -$2.40 M(+60.0%) |
| June 1990 | -$1.50 M(+400.0%) | -$1.80 M(-1900.0%) | -$1.50 M(+1400.0%) |
| Mar 1990 | - | $100.00 K(0.0%) | -$100.00 K(0.0%) |
| Dec 1989 | - | $100.00 K(0.0%) | -$100.00 K(0.0%) |
| Sept 1989 | - | $100.00 K(-125.0%) | -$100.00 K(0.0%) |
| June 1989 | -$300.00 K | -$400.00 K(-500.0%) | -$100.00 K(-133.3%) |
| Mar 1989 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Dec 1988 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Sept 1988 | - | $100.00 K | $100.00 K |
FAQ
- What is BioLife Solutions annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for BioLife Solutions?
- What is BioLife Solutions annual EBITDA year-on-year change?
- What is BioLife Solutions quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for BioLife Solutions?
- What is BioLife Solutions quarterly EBITDA year-on-year change?
- What is BioLife Solutions TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for BioLife Solutions?
- What is BioLife Solutions TTM EBITDA year-on-year change?
What is BioLife Solutions annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BLFS is -$45.24 M
What is the all time high annual EBITDA for BioLife Solutions?
BioLife Solutions all-time high annual earnings before interest, taxes, depreciation & amortization is $2.57 M
What is BioLife Solutions annual EBITDA year-on-year change?
Over the past year, BLFS annual earnings before interest, taxes, depreciation & amortization has changed by -$21.80 M (-92.99%)
What is BioLife Solutions quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BLFS is $853.00 K
What is the all time high quarterly EBITDA for BioLife Solutions?
BioLife Solutions all-time high quarterly earnings before interest, taxes, depreciation & amortization is $58.57 M
What is BioLife Solutions quarterly EBITDA year-on-year change?
Over the past year, BLFS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$12.82 M (+107.13%)
What is BioLife Solutions TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BLFS is -$37.71 M
What is the all time high TTM EBITDA for BioLife Solutions?
BioLife Solutions all-time high TTM earnings before interest, taxes, depreciation & amortization is $40.27 M
What is BioLife Solutions TTM EBITDA year-on-year change?
Over the past year, BLFS TTM earnings before interest, taxes, depreciation & amortization has changed by -$72.61 M (-208.04%)